The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Open accessAbstract
BACKGROUND: Seizures and their consequences contribute to the burden of epilepsy because they can cause health loss (premature mortality and residual disability). Data on the burden of epilepsy are needed for health-care planning and resource allocation. The aim of this study was to quantify health loss due to epilepsy by age, sex, year, and location using data from the Global Burden of Diseases, Injuries, and Risk Factors Study. METHODS: We assessed the burden of epilepsy in 195 countries and territories from 1990 to 2016. Burden was measured as deaths, prevalence, and disability-adjusted life-years (DALYs; a summary measure of health loss defined by the sum of years of life lost [YLLs] for premature mortality and years lived with disability), by age, sex, year, location, and Socio-demographic Index (SDI; a compound measure of income per capita, education, and fertility). Vital registrations and verbal autopsies provided information about deaths, and data on the prevalence and severity of epilepsy largely came from population representative surveys. All estimates were calculated with 95% uncertainty intervals (UIs). FINDINGS: In 2016, there were 45·9 million (95% UI 39·9-54·6) patients with all-active epilepsy (both idiopathic and secondary epilepsy globally; age-standardised prevalence 621·5 per 100 000 population; 540·1-737·0). Of these patients, 24·0 million (20·4-27·7) had active idiopathic epilepsy (prevalence 326·7 per 100 000 population; 278·4-378·1). Prevalence of active epilepsy increased with age, with peaks at 5-9 years (374·8 [280·1-490·0]) and at older than 80 years of age (545·1 [444·2-652·0]). Age-standardised prevalence of active idiopathic epilepsy was 329·3 per 100 000 population (280·3-381·2) in men and 318·9 per 100 000 population (271·1-369·4) in women, and was similar among SDI quintiles. Global age-standardised mortality rates of idiopathic epilepsy were 1·74 per 100 000 population (1·64-1·87; 1·40 per 100 000 population [1·23-1·54] for women and 2·09 per 100 000 population [1·96-2·25] for men). Age-standardised DALYs were 182·6 per 100 000 population (149·0-223·5; 163·6 per 100 000 population [130·6-204·3] for women and 201·2 per 100 000 population [166·9-241·4] for men). The higher DALY rates in men were due to higher YLL rates compared with women. Between 1990 and 2016, there was a non-significant 6·0% (-4·0 to 16·7) change in the age-standardised prevalence of idiopathic epilepsy, but a significant decrease in age-standardised mortality rates (24·5% [10·8 to 31·8]) and age-standardised DALY rates (19·4% [9·0 to 27·6]). A third of the difference in age-standardised DALY rates between low and high SDI quintile countries was due to the greater severity of epilepsy in low-income settings, and two-thirds were due to a higher YLL rate in low SDI countries. INTERPRETATION: Despite the decrease in the disease burden from 1990 to 2016, epilepsy is still an important cause of disability and mortality. Standardised collection of data on epilepsy in population representative surveys will strengthen the estimates, particularly in countries for which we currently have no or sparse data and if additional data is collected on severity, causes, and treatment. Sizeable gains in reducing the burden of epilepsy might be expected from improved access to existing treatments in low-income countries and from the development of new effective drugs worldwide. FUNDING: Bill & Melinda Gates Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Forouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698
Self-citationVos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253
Self-citationILAE official report: a practical clinical definition of epilepsy
Fisher, R. S., Acevedo, C., Arzimanoglou, A., Bogacz, A., Cross, J. H., Elger, C. E., Engel, J., Forsgren, L., French, J. A., Glynn, M., et al. (2014) · Epilepsia · doi:10.1111/epi.12550 · Cited by 6,108
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Self-citationScheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2017) · Epilepsia · doi:10.1111/epi.13709 · Cited by 5,054
Naghavi, M., Abajobir, A. A., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abera, S. F., Aboyans, V., Adetokunboh, O., Afshin, A., Agrawal, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32152-9 · Cited by 4,821
Self-citationFisher, R. S., Boas, W. V. E., Blume, W., Elger, C., Genton, P., Lee, P., & Engel, J. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.66104.x · Cited by 3,671
Fisher, R. S., Cross, J. H., French, J. A., Higurashi, N., Hirsch, E., Jansen, F. E., Lagae, L., Moshé, S. L., Peltola, J., Roulet Perez, E., et al. (2017) · Epilepsia · doi:10.1111/epi.13670 · Cited by 3,483
Gakidou, E., Afshin, A., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Aboyans, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32366-8 · Cited by 2,406 · cited 1×
“14 Additional details on calculations can be found in the GBD 2016 risk factor overview paper 15 and in the appendix.”
BackgroundSelf-citationBeghi, E., Berg, A., Carpio, A., Forsgren, L., Hesdorffer, D. C., Hauser, W. A., Malmgren, K., Shinnar, S., Temkin, N., Thurman, D., et al. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00273_1.x · Cited by 2,296
Self-citation
Cited by
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Self-citationYap, J. Y. Y., Keatch, C., Lambert, E., Woods, W., Stoddart, P. R., & Kameneva, T. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00284 · Cited by 432
Sen, A., Jette, N., Husain, M., & Sander, J. W. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33064-8 · Cited by 369
The global burden of epilepsy report: implications for low-and middle-income countries
Singh, G., & Sander, J. W. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.106949 · Cited by 255
Self-citationCano, A., Sánchez-López, E., Ettcheto, M., López-Machado, A., Espina, M., Souto, E. B., Galindo, R., Camins, A., García, M. L., & Turowski, P. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0443 · Cited by 144
Metadata
- Authors
- Beghi, E., Giussani, G., Nichols, E., Abd-Allah, F., Abdela, J., Abdelalim, A., Abraha, H. N., Adib, M. G., Agrawal, S., Alahdab, F., Awasthi, A., Ayele, Y., Barboza, M. A., Belachew, A. B., Biadgo, B., Bijani, A., Bitew, H., Carvalho, F., Chaiah, Y., Daryani, A., Do, H. P., Dubey, M., Endries, A. Y. Y., Eskandarieh, S., Faro, A., Farzadfar, F., Fereshtehnejad, S.-M., Fernandes, E., Fijabi, D. O., Filip, I., Fischer, F., Gebre, A. K., Tsadik, A. G., Gebremichael, T. G., Gezae, K. E., Ghasemi-Kasman, M., Weldegwergs, K. G., Degefa, M. G., Gnedovskaya, E. V., Hagos, T. B., Haj-Mirzaian, A., Haj-Mirzaian, A., Hassen, H. Y., Hay, S. I., Jakovljevic, M., Kasaeian, A., Kassa, T. D., Khader, Y. S., Khalil, I., Khan, E. A., Khubchandani, J., Kisa, A., Krohn, K. J., Kulkarni, C., Nirayo, Y. L., Mackay, M. T., Majdan, M., Majeed, A., Manhertz, T., Mehndiratta, M. M., Mekonen, T., Meles, H. G., Mengistu, G., Mohammed, S., Naghavi, M., Mokdad, A. H., Mustafa, G., Irvani, S. S. N., Nguyen, L. H., Nixon, M. R., Ogbo, F. A., Olagunju, A. T., Olagunju, T. O., Owolabi, M. O., Phillips, M. R., Pinilla-Monsalve, G. D., Qorbani, M., Radfar, A., Rafay, A., Rahimi-Movaghar, V., Reinig, N., Sachdev, P. S., Safari, H., Safari, S., Safiri, S., Sahraian, M. A., Samy, A. M., Sarvi, S., Sawhney, M., Shaikh, M. A., Sharif, M., Singh, G., Smith, M., Szoeke, C. E. I., Tabarés-Seisdedos, R., Temsah, M.-H., Temsah, O., Tortajada-Girbés, M., Tran, B. X., Tsegay, A. A. T., Ullah, I., Venketasubramanian, N., Westerman, R., Winkler, A. S., Yimer, E. M., Yonemoto, N., Feigin, V. L., Vos, T., & Murray, C. J. L.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Haramaya University (ET)
- Cairo University (EG)
- Corresponding author
- Beghi, Ettore
- ORCID
- Beghi, Ettore
- Giussani, Giorgia
- Nichols, Emma
- Abd-Allah, Foad
- Abdela, Jemal
- Abdelalim, Ahmed
- Abraha, Haftom Niguse
- Agrawal, Sutapa
- Alahdab, Fares
- Awasthi, Ashish
- Ayele, Yohanes
- Barboza, Miguel A
- Belachew, Abate Bekele
- Biadgo, Belete
- Bijani, Ali
- Bitew, Helen
- Carvalho, Félix
- Chaiah, Yazan
- Daryani, Ahmad
- Do, Huyen Phuc
- Dubey, Manisha
- Endries, Aman Yesuf Yesuf
- Eskandarieh, Sharareh
- Farzadfar, Farshad
- Fereshtehnejad, Seyed-Mohammad
- Fernandes, Eduarda
- Filip, Irina
- Fischer, Florian
- Gebre, Abadi Kahsu
- Tsadik, Afewerki Gebremeskel
- Gebremichael, Teklu Gebrehiwo
- Gezae, Kebede Embaye
- Degefa, Meaza Girma
- Gnedovskaya, Elena V.
- Hassen, Hamid Yimam
- Hay, Simon I
- Kasaeian, Amir
- Kassa, Tesfaye Dessale
- Khader, Yousef Saleh
- Khan, Ejaz Ahmad
- Khubchandani, Jagdish
- Mackay, Mark T
- Majeed, Azeem
- Meles, Hagazi Gebre
- Mohammed, Shafiu
- Naghavi, Mohsen
- Mokdad, Ali H
- Mustafa, Ghulam
- Irvani, Seyed Sina Naghibi
- Nguyen, Long Hoang
- Ogbo, Felix Akpojene
- Olagunju, Andrew T
- Olagunju, Tinuke O
- Owolabi, Mayowa Ojo
- Pinilla-Monsalve, Gabriel David
- Qorbani, Mostafa
- Radfar, Amir
- Sachdev, Perminder S
- Safari, Hosein
- Safari, Saeed
- Safiri, Saeid
- Sahraian, Mohammad Ali
- Samy, Abdallah M.
- Sarvi, Shahabeddin
- Singh, Gagandeep
- Szoeke, Cassandra E I
- Temsah, Mohamad-Hani
- Tran, Bach Xuan
- Tsegay, Amanuel Amanuel Tesfay
- Ullah, Irfan
- Venketasubramanian, Narayanaswamy
- Westerman, Ronny
- Winkler, Andrea Sylvia
- Yimer, Ebrahim M
- Yonemoto, Naohiro
- Feigin, Valery L.
- Vos, Theo
- Murray, Christopher J L
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 18
- Issue
- 4
- Pages
- 357-375
- ISSN
- 1474-4422 (ISSN-L)
- PMC
- PMC6416168
- OpenAlex
- W2911226018
- Cited by
- 1,036
- References
- 41
- Citations by year
- 2026: 120 · 2025: 189 · 2024: 173 · 2023: 169 · 2022: 135 · 2021: 132 · 2020: 94 · 2019: 23
- FWCI
- 76.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet Neurology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Tuwhera (Auckland University of Technology) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion, other-oa)
- Publikationen an der Universität Bielefeld (Universität Bielefeld) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- Funders
- Fundação para a Ciência e a Tecnologia
- Ministerio de Educación, Cultura y Deporte
- Alzheimer's Association
- Generalitat Valenciana (PI17/00719)
- European Commission (POCI/01/0145/FEDER/007265)
- Ministério da Educação e Ciência (PT2020 UID/QUI/50006/2013, UID/MULTI/04378/2013)
- National Health and Medical Research Council
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (OI175014)
- Department of Science and Technology, Ministry of Science and Technology, India
- H. Lundbeck A/S
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Health and Epidemiology
- Keywords
- epilepsy, epilepsy prevalence, idiopathic epilepsy, symptomatic epilepsy, disability-adjusted life years, years of life lost, epilepsy mortality, epilepsy-related death, health loss, socio-demographic index, age-standardized prevalence, Global Burden of Disease Study 2016, verbal autopsy, civil registration, health planning, resource allocation
- MeSH terms
- Global Burden of Disease, Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Autopsy, Cause of Death, Child, Child, Preschool, Epilepsy, Female, Persons with Disabilities, Health Surveys, Humans, Infant, Male, Middle Aged, Risk Factors, Seizures, Sex Factors, Socioeconomic Factors, Prevalence, Cost of Illness, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. https://app.cochat.ai/papers/10.1016/s1474-4422(18)30454-x
- The paper
- Beghi, E., Giussani, G., Nichols, E., Abd-Allah, F., Abdela, J., Abdelalim, A., Abraha, H. N., Adib, M. G., Agrawal, S., Alahdab, F., Awasthi, A., Ayele, Y., Barboza, M. A., Belachew, A. B., Biadgo, B., Bijani, A., Bitew, H., Carvalho, F., Chaiah, Y., . . . Murray, C. J. L. (2019). Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(18)30454-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.